Skip to content
DraconiticResearch
Search Sources API
182,469 studies31 sourcesUpdated 13 min ago
Peer-reviewedCC BYMedicina (Kaunas, Lithuania)

Long-Term Major Adverse Kidney and Cardiovascular Events in Predialysis Chronic Kidney Disease: A Real-World Cohort Study

6 affiliations
  1. 1Department of Internal Medicine, The , 07080 Antalya, Turkey;
  2. 2Nephrology Department, Faculty of Medicine, , 07058 Antalya, Turkey;
  3. 3Cardiology Department, Antalya Training and Research Hospital, 07100 Antalya, Turkey;
  4. 4Department of Public Health, Faculty of Medicine, , 03030 Afyonkarahisar, Turkey;
  5. 5Internal Medicine Department, Antalya Training and Research Hospital, 07100 Antalya, Turkey;
  6. 6Nephrology Department, Antalya Training and Research Hospital, 07100 Antalya, Turkey;

Related

  1. Explainable Machine Learning for Predicting Major Adverse Renal and Cardiovascular Events in Acute Myocardial Infarction With Chronic Kidney Disease: Algorithm Development and Validation
    Wang Feng, Ruihao Jiang, Wendi Huang +6
    JMIR Medical InformaticsPeer-reviewedCC BYFull textCardiovascular medicineDOAJEurope PMCPMC
  2. Short-term clinical efficacy and recorded adverse events of semaglutide combined with dapagliflozin in patients with type 2 diabetes mellitus and chronic kidney disease
    Cheng Gong, Qiong Luo, Qin Li
    MedicinePeer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. Achieved systolic blood pressure and cardiovascular outcomes in advanced chronic kidney disease
    Clinical kidney journalPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. 2026 ESC Guidelines for the management of cardiovascular disease and chronic kidney disease, in collaboration with the European Renal Association (ERA): Developed by the task force on the management of cardiovascular disease and chronic kidney disease of the European Society of Cardiology (ESC)
    Kevin Damman, Jozine M. ter Maaten, Kaitlin J. Mayne +97
    ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam)Peer-reviewedCC BY-SAFull text21 citedCardiovascular medicineOpenAlexOpenAlex
  5. Lipoprotein(a): a potential target for the reduction of residual cardiovascular risk in patients with chronic kidney disease.
    Leonardo A Sechi, Luca Bulfone, Antonio Vacca +5
    Frontiers in nephrologyPeer-reviewedCC BYFull textSurgery & anaesthesiaEurope PMC
BibTeX
@article{avcı2026longterm,
  title = {{Long-Term Major Adverse Kidney and Cardiovascular Events in Predialysis Chronic Kidney Disease: A Real-World Cohort Study}},
  author = {Ayşe Karaduru Avcı and Ayca Inci and Rauf Avcı and Uğur Büyükokudan and Fatih Sargin and Lütfullah Zahit Koç and Üstün Yılmaz},
  journal = {Medicina (Kaunas, Lithuania)},
  year = {2026},
  month = oct,
  url = {https://europepmc.org/article/PMC/PMC13706874},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Long-Term Major Adverse Kidney and Cardiovascular Events in Predialysis Chronic Kidney Disease: A Real-World Cohort Study
AU  - Ayşe Karaduru Avcı
AU  - Ayca Inci
AU  - Rauf Avcı
AU  - Uğur Büyükokudan
AU  - Fatih Sargin
AU  - Lütfullah Zahit Koç
AU  - Üstün Yılmaz
PY  - 2026
DA  - 2026/10/01
JO  - Medicina (Kaunas, Lithuania)
UR  - https://europepmc.org/article/PMC/PMC13706874
SN  - 1010-660X
SN  - 1648-9144
ER  -